Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label single-arm study of human fibrinogen in congenital hypofibrinogenemia or afibrinogenemia
CTR20251349Phase 3Active
- Sponsor
- Zhengzhou RAAS
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, congenital afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, sponsored by Zhengzhou RAAS. Started Jun 2025; status: active.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiencycongenital afibrinogenemiahypofibrinogenemiadysfibrinogenemia
Beyond the preview
Go deeper on CTR20251349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251349.